Loading clinical trials...
Loading clinical trials...
First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.A Multicentre, Phase III Randomized Study by the PLRG.
Conditions
Interventions
Rituximab
Cyclophosphamide
+4 more
Locations
12
Poland
Podkarpacki Oncology Centre
Brzozów, Poland
Voivodeship Hospital, Oncology Ward
Elblag, Poland
Academic Clinical Centre, Hospital of Medical Academy, Clinic of Haematology and Transplantology
Gdansk, Poland
Silesian Medical University, Chair and Clinic of Haematology and Bone Marrow Transplantation
Katowice, Poland
Collegium Medicum Jagiellonian University, Clinic of Haematology
Krakow, Poland
Regional Oncology Centre, Ward of Proliferative Diseases
Lodz, Poland
Start Date
February 1, 2007
Primary Completion Date
June 25, 2017
Completion Date
June 25, 2017
Last Updated
July 17, 2017
NCT06337318
NCT05006716
NCT06026319
NCT06510361
NCT07128641
NCT05254743
Lead Sponsor
Polish Lymphoma Research Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions